INHSU Report: Six Key Components of Point-of-Care Testing Programs
Findings from the 2025 INHSU Point-of-Care Testing Forum at the Global Hepatitis Summit, held in Los Angeles, USA on 18-21 March 2025. More
Calendar
Recent materials
Development Dimensions of Drug Policy: Assessing New Challenges, Uncovering Opportunities, and Addressing Emerging Issues
UNDP releases a discussion paper examining how drug policy affects sustainable development, human rights, governance, health, and the environment. More
European Cities on the Frontline: Harm Reduction and Drug Policy – Needs, Best Practices and Recommendations
C-EHRN releases a report underlining the crucial role of municipal leadership, cross-sectoral cooperation, and community engagement in building resilient harm reduction responses. More
Urgent Call for Continued WHO Leadership on Harm Reduction for People Who Use Drugs
Advocates sent an open letter to WHO Director-General, urging WHO to maintain its strong presence within the harm reduction, human rights and drug policy spaces, and to ensure the continuation of its crucial work in support of people who use drugs. More
Harm Reduction in Europe: Histories, Choices and Hopes
Harm Reduction Journal releases a thematic series on harm reduction, providing a comprehensive and insightful look into the journey of harm reduction across the diverse regions of Europe. More
Viral Hepatitis Elimination Barometer Among PWID in Europe
EUDA updates tool for tracking progress in eliminating viral hepatitis in people who inject drugs. More
